Abstract
Novel peptides originating from the peptide inhibitor of myosin light chain kinase (MLCK), L-PIK (Arg-Lys-Lys-Tyr-Lys-Tyr-Arg-Arg-Lys), have been studied for their ability to attenuate the thrombin-induced hyperpermeability of an endothelial cell monolayer in culture. Peptides [NαMeArg1]-Lys-Lys-Tyr-Lys-Tyr-Arg-(D)Arg8-Lys and H-Arg(NO2)Lys-Lys-Tyr-Lys-Tyr-Arg-Arg-Lys-NH2 (designated PIK2 and PIK4, respectively) appeared to be the most effective inhibitors of endothelial cell monolayer hyperpermeability, and surpassed other known peptide inhibitors of MLCK derived from original L-PIK. Our results validate PIK2 and PIK4 as the leading molecules for the development of novel drugs intended to counteract pathological hyperpermeability of vascular endothelium.
Similar content being viewed by others
References
M. S. Wainwright, J. Rossi, J. Schavocky, et al., Proc. Natl. Acad. Sci. USA. 100, 6233 (2003).
T. Mirzapoiazova, J. Moitra, L. Moreno-Vinasco, et al., Am. J. Respir. Cell Mol. Biol. 44, 40 (2011).
H. A. Behanna, D. M. Watterson, and H. R. Ranaivo, Biochim. Biophys. Acta 1763, 1266 (2006).
J. L. Rossi, A. V. Velentza, D. M. Steinhorn, et al., Am. J. Physiol. Lung Cell Mol. Physiol. 292, L1327 (2007).
M. Ikebe, M. Stepinska, B. E. Kemp, et al., J. Biol. Chem. 262, 13828 (1987).
T. J. Lukas, S. Mirzoeva, U. Slomczynska, and D. M. Watterson, J. Med. Chem. 42, 910 (1999).
D. R. Clayburgh, T. A. Barrett, Y. Tang, et al., J. Clin. Invest. 115(10), 2702 (2005).
S. E. Owens, W. V. Graham, D. Siccardi, et al., Pharm. Res. 22, 703 (2005).
A. V. Sekridova, M. V. Sidorova, A. A. Az’muko, et al., Bioorg. Khim. 36, 461 (2010).
A. V. Marchenko, M. V. Sidorova, A. V. Sekridova, et al., Ross. Fiziol. Zh. im. I.M. Sechenova 95, 507 (2009).
A. V. Marchenko, E. O. Stepanova, A. V. Sekridova, et al., Biofizika 55, 1008 (2010).
M. W. Pennington, in Peptide Synthesis Protocols, Ed. by W. Pennington and M. B. Dunn (Humane Press, Totowa NJ, 1994), p. 241.
A. Quesnel, A. Zerbib, F. Connan, et al., J. Peptide Sci. 7, 157 (2001).
I. P. Ashmarin, Neurochemical J. 1, 173 (2007).
V. J. Hruby and G. G. Bonner, in Peptide Synthesis Protocols, Ed. by W. Pennington and M. B. Dunn (Humane Press, Totowa NJ, 1994), p. 201.
S. R. Schwarze, A. Ho, A. Vocero-Akbani, and S. F. Dowdy, Science 285, 1569 (1999).
C. J. Edgell, C. C. McDonald, and J. B. Graham, Proc. Natl. Acad. Sci. USA 80, 3734 (1983).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.Y. Khapchaev, M.V. Samsonov, O.A. Kazakova, E.L. Vilitkevich, M.V. Sidorova, A.A. Az’muko, A.S. Molokoedov, Zh.D. Bespalova, V.P. Shirinsky, 2012, published in Biofizika, 2012, Vol. 57, No. 5, pp. 764–770.
Translation of the text provided by the authors; redaction imposed solely for consistency and comprehensibility.
Rights and permissions
About this article
Cite this article
Khapchaev, A.Y., Samsonov, M.V., Kazakova, O.A. et al. Suppression of vascular endothelium hyperpermeability by cell-permeating peptide inhibitors of myosin light chain kinase. BIOPHYSICS 57, 587–591 (2012). https://doi.org/10.1134/S0006350912050089
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350912050089